• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down2.84% Nasdaq Down2.94%

    Acura Pharmaceuticals, Inc. (ACUR)

    -NasdaqCM
    2.97 Down 0.08(2.62%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 341   5,357   529   145  
    Cost of Revenue98  324  39  108  
    Gross Profit 243   5,033   490   37  
    Operating Expenses
    Research Development511  964  908  955  
    Selling General and Administrative2,083  2,297  2,037  1,728  
    Non Recurring47  260   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (2,398) 1,512   (2,455) (2,646)
    Income from Continuing Operations
    Total Other Income/Expenses Net36  35  64  46  
    Earnings Before Interest And Taxes(2,362)1,547  (2,391)(2,600)
    Interest Expense301  308  305  304  
    Income Before Tax(2,663)1,239  (2,696)(2,904)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(2,663)1,239  (2,696)(2,904)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (2,663) 1,239   (2,696) (2,904)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (2,663) 1,239   (2,696) (2,904)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.